Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Clinical Pharmacokinetics
|
October 8, 1999
Olanzapine. Pharmacokinetic and pharmacodynamic profile
J T Callaghan, R F Bergstrom, L R Ptak, et al.
European Journal of Neurology
|
June 7, 2017
Principles of proportional recovery after stroke generalize to neglect and aphasia
N A Marchi, R Ptak, M Di Pietro, et al.
Chemical & Pharmaceutical Bulletin
|
January 5, 2002
Measurement of the length of the a helical section of a peptide directly using atomic force microscopy
S Takeda, R Ptak, C Nakamura, et al.
Frontiers in Human Neuroscience
|
September 25, 2013
Effects of pro-cholinergic treatment in patients suffering from spatial neglect
N Lucas, A Saj, S Schwartz, et al.
Pharmacology, Biochemistry, and Behavior
|
September 1, 1993
Alterations in striatal neurotrophic activity induced by dopaminergic drugs
P M Carvey, L R Ptak, D Lin, et al.
Neurology
|
May 1, 1991
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease
P M Carvey, A McRae, T F Lint, et al.
Experimental Neurology
|
March 1, 1993
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures
P M Carvey, L R Ptak, S T Nath, et al.
Experimental Neurology
|
October 1, 1991
Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures
P M Carvey, L R Ptak, E S Lo, et al.
Neurotoxicology and Teratology
|
March 1, 1994
Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity
D E Weese-Mayer, J M Silvestri, D Lin, et al.
Progress in Brain Research
|
January 1, 1990
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor
P M Carvey, A McRae, L R Ptak, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Clinical Pharmacokinetics
|
October 8, 1999
Olanzapine. Pharmacokinetic and pharmacodynamic profile
J T Callaghan, R F Bergstrom, L R Ptak, et al.
European Journal of Neurology
|
June 7, 2017
Principles of proportional recovery after stroke generalize to neglect and aphasia
N A Marchi, R Ptak, M Di Pietro, et al.
Chemical & Pharmaceutical Bulletin
|
January 5, 2002
Measurement of the length of the a helical section of a peptide directly using atomic force microscopy
S Takeda, R Ptak, C Nakamura, et al.
Frontiers in Human Neuroscience
|
September 25, 2013
Effects of pro-cholinergic treatment in patients suffering from spatial neglect
N Lucas, A Saj, S Schwartz, et al.
Pharmacology, Biochemistry, and Behavior
|
September 1, 1993
Alterations in striatal neurotrophic activity induced by dopaminergic drugs
P M Carvey, L R Ptak, D Lin, et al.
Neurology
|
May 1, 1991
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease
P M Carvey, A McRae, T F Lint, et al.
Experimental Neurology
|
March 1, 1993
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures
P M Carvey, L R Ptak, S T Nath, et al.
Experimental Neurology
|
October 1, 1991
Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures
P M Carvey, L R Ptak, E S Lo, et al.
Neurotoxicology and Teratology
|
March 1, 1994
Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity
D E Weese-Mayer, J M Silvestri, D Lin, et al.
Progress in Brain Research
|
January 1, 1990
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor
P M Carvey, A McRae, L R Ptak, et al.
Page
of 3